Glenmark Life Sciences filed a draft red herring prospectus (DRHP) with SEBI for an IPO
Glenmark Life Sciences (GLS; Glenmark Pharma’s 100% auxiliary for API or dynamic drugs fixings) filed a draft red herring prospectus
Read moreGlenmark Life Sciences (GLS; Glenmark Pharma’s 100% auxiliary for API or dynamic drugs fixings) filed a draft red herring prospectus
Read more